Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -4.39 is 99% above its 5-year average of -610.60, near the high end of its 5-year range (-2088.00–-4.39).
90.08% above its 12-month average of -44.24.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.74.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 19 comparable quarters.
EARNINGS PER SHARE (EPS)
-4.39
EARNINGS PER SHARE (EPS) AVG TTM
-44.24
EARNINGS PER SHARE (EPS) AVG 3Y
-644.57
EARNINGS PER SHARE (EPS) AVG 5Y
-610.60
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+90.08%
CURRENT VS 3Y AVG
+99.32%
CURRENT VS 5Y AVG
+99.28%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Dermata Therapeutics, Inc.
Market Cap
$4.55M
Earnings Per Share (EPS)
-4.39
TTM Avg
-44.24
3Y Avg
-644.57
5Y Avg
-610.60
Market Cap
$4.42M
Earnings Per Share (EPS)
-9.39
TTM Avg
-11.95
3Y Avg
-11.32
5Y Avg
-8.88
Market Cap
$4.41M
Earnings Per Share (EPS)
-18.85
TTM Avg
-47.63
3Y Avg
-99.69
5Y Avg
-316.96
Market Cap
$4.32M
Earnings Per Share (EPS)
-0.76
TTM Avg
-0.88
3Y Avg
-0.66
5Y Avg
-0.44
Market Cap
$4.79M
Earnings Per Share (EPS)
-5.32
TTM Avg
-8.47
3Y Avg
-12.67
5Y Avg
-14.30
Market Cap
$4.80M
Earnings Per Share (EPS)
-3.64
TTM Avg
-254.03
3Y Avg
-3442.01
5Y Avg
-5629.67
Market Cap
$4.85M
Earnings Per Share (EPS)
-6.95
TTM Avg
-22.18
3Y Avg
-69.66
5Y Avg
-91.58
Market Cap
$4.96M
Earnings Per Share (EPS)
N/A
TTM Avg
0.00
3Y Avg
-0.12
5Y Avg
-0.11
Market Cap
$4.11M
Earnings Per Share (EPS)
N/A
TTM Avg
-60.73
3Y Avg
-46926.80
5Y Avg
-32538.00
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dermata Therapeutics, Inc. (DRMA) | $4.55M | -4.39 | -44.24 | -644.57 | -610.60 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.42M | -9.39 | -11.95 | -11.32 | -8.88 |
| Ernexa Therapeutics Inc. (ERNA)vs › | $4.41M | -18.85 | -47.63 | -99.69 | -316.96 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.32M | -0.76 | -0.88 | -0.66 | -0.44 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.79M | -5.32 | -8.47 | -12.67 | -14.30 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.80M | -3.64 | -254.03 | -3442.01 | -5629.67 |
| CalciMedica, Inc. (CALC)vs › | $4.85M | -6.95 | -22.18 | -69.66 | -91.58 |
| Gelteq Limited Ordinary Shares (GELS)vs › | $4.96M | N/A | 0.00 | -0.12 | -0.11 |
| GRI Bio, Inc. (GRI)vs › | $4.11M | N/A | -60.73 | -46926.80 | -32538.00 |
| Aptevo Therapeutics Inc. (APVO)vs › | $4.02M | -211.18 | -432751.00 | -875189.50 | -22462429.83 |
Trailing EPS (TTM)
$-4.39
Forward EPS (Est.)
$-2.17
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -8.16 |
| 2024-12-31 | -80.32 |
| 2023-12-31 | -401.80 |
| 2022-12-31 | -2088.00 |
| 2021-12-31 | -152.70 |
| 2020-12-31 | -932.64 |
| 2019-12-31 | -95.50 |
